To the Editor:
We read with great interest the recent article on the anesthetic management of aortic dissection repair in patients with suspected severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. We would like to call your attention to our case, which sheds additional light on this topic. We report a case of a 50-year-old man admitted to the emergency department of A. Gemelli University Hospital in Rome, Italy, on March 11, 2020 for acute aortic dissection, who developed disseminated intravascular coagulation (DIC) in the immediate postoperative period. His symptomatology was characterized by syncope on the day before, without chest pain or dyspnea. Emergency computed tomographic scan showed a DeBakey II aortic dissection and pericardial effusion (Fig 1 ). No pulmonary alteration was observed. Afebrile at admission, he had traveled in Northern Italy, deemed to be at high risk for COVID-19 spread, and had a mild fever for the week before. Due to epidemiologic criteria, a nasopharyngeal swab was obtained for SARS-CoV-2 RNA test according to local protocol at the time, which ultimately was negative. The patient immediately underwent emergency surgery and all medical staff adopted third-level medical protection measures for COVID-19 safety procedures, including properly wearing disposable protective clothing, medical-grade masks such as N95, disposable surgical caps, medical-grade goggles, disposable latex gloves, and disposable shoe covers. The ascending aorta was replaced, requiring 20 minutes of hypothermic (28°C) circulatory arrest and selective brain perfusion. The patient was transferred to an isolation intensive care unit room and specific measures for infection containment were established despite the admission test being negative. In the intensive care unit, the patient presented massive bleeding from chest drainage. Rotational thromboelastometry (Tem GmbH, Germany) tests showed a hypercoagulable state, with secondary fibrinolysis, suggestive for a DIC condition like blood tests.1 Coagulation derangement was treated and after 2 surgical revisions, without evidence of the surgical source of bleeding, a mediastinal packing was performed. Bleeding reduced substantially during the first postoperative day, and sternosynthesis was performed. Four days after surgery, the patient developed shock associated with multiorgan failure, fever, and increased Sequential Organ Failure Assessment score. Due to worsening of gas exchange and chest x-ray evidence of interstitial strengthening, a deep bronchoalveolar lavage (BAL) was performed for a second SARS-CoV-2 RNA test, which turned out to be positive. The patient died after 10 days.
Fig 1.
CT scan images. CT scan of the aorta shows 3-dimensional image reconstruction of thickened aortic wall originating from the sinotubular junction, ascending portion with a maximum diameter of 45 mm, without involvement of the epiaortic arterial branches. Without involvement of arch of aorta. Ascending aortic dissection and thickened aortic wall with pericardial and pericardial effusion. No pulmonary alteration in progress. CT, computed tomography.
In our opinion, there are at least 2 aspects in this case that are worthy of being discussed. First, the presence of a high suspicion of COVID-19 is essential to adopt specific measures for infection containment, because false-negative results could hinder the prevention and control of the epidemic.2 In a recent research letter, Wang et al showed that 93% of BAL swabs were positive in patients with confirmed SARS-CoV-2 compared to only 63% of nasal swabs,3 probably due to the persistence in the lower respiratory tract. In our patient, it was essential to provide adequate personal protective equipment to healthcare professionals, and in a patient with suspected COVID-19–associated pneumonia, additional lower respiratory tract sampling was performed by trained and dedicated personnel according to World Health Organization guidelines.4
Second, the onset of immediate and massive bleeding associated with an overt DIC (International Society on Thrombosis and Haemostasis DIC score >5)5 worsened the prognosis. The pathogenesis of DIC related to aortic dissection is associated with thrombus formation inside the dissected lumen and often is classified as an enhanced fibrinolytic process.6 Disseminated intravascular coagulation can originate from and cause damage to the microvasculature, which can produce organ dysfunction if sufficiently severe.5 In cardiac surgery, cardiopulmonary bypass often induces a systemic inflammatory response syndrome, which includes cascades of coagulation and a fibrinolytic condition.7 A relation between poor prognosis and development of coagulopathy was described also in SARS-CoV-2 infection.8, 9, 10 In a recent study, Tang et al11 investigated the role of coagulopathy in severe novel coronavirus pneumonia. Indeed, they highlighted how DIC appeared in most of the deaths associated with a diagnosis of COVID-19. At the late stages of novel coronavirus pneumonia, the authors described how the levels of fibrin-related markers were elevated moderately or markedly in all deaths, which suggested coagulation activation and secondary hyperfibrinolysis condition. Nevertheless, coagulopathy often seems to be associated with pulmonary intravascular coagulation (PIC) and where DIC develops, it is restricted to late-stage disease.12 SARS-CoV-2 may lead to an increase of intrapulmonary inflammation and PIC due to tropism for angiotensin-converting enzyme 2 receptor and its downregulation on type II pneumocytes.13 But compared to DIC, during PIC, SARS-CoV-2–related platelet counts and fibrinogen concentration are not reduced substantially, despite marked increases in D-dimer concentration.14 Autopsy series showed bilateral alveolar damage and fibrin thrombi within alveolar capillaries, with right ventricular dilatation as a possible effect of pulmonary hypertension,15 associated with hemorrhagic necrosis.16 Thrombosis mainly involves lungs but not other organs; hemorrhage is intrapulmonary and not generalized, and liver function is preserved.17 In our patient, coagulation disorder seemed to be DIC- related, with generalized bleeding, persistent elevated D-dimer concentrations during 5 days after surgery, reduced platelet and fibrinogen values, and elevated liver function markers. After after surgery, we registered elevated cardiac enzyme concentrations and mild pulmonary hypertension, which does not exclude PIC but may be related to cardiac surgery. In conclusion, DIC, potentially SARS-CoV-2 infection- related, has preceded the pulmonary pattern, but the concomitant aortic dissection and cardiac surgery inflammatory response may have played a substantial role in triggering DIC, resulting in an overlap of severe pathologic conditions. According to our experience, we suggest using third-level medical protection measures for COVID-19 in emergency cardiac surgery until a definite diagnosis is made, considering that BAL is a more specific and sensible test than nasopharyngeal swab in intubated patients. We also suggest that SARS-CoV-2 infection may play a role in exacerbating and potentiating the inflammatory response and coagulopathy in aortic dissection surgery, resulting in potentially greater risk of DIC and bleeding in the postoperative period.
Conflict of Interest
None.
References
- 1.Fukui T. Management of acute aortic dissection and thoracic aortic rupture. J Intensive Care. 2018;6:15. doi: 10.1186/s40560-018-0287-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Lillie P.J., Samson A., Li A. Novel coronavirus disease (Covid-19): The first two patients in the UK with person to person transmission. J Infect. 2020;80:578–606. doi: 10.1016/j.jinf.2020.02.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Wang W., Xu Y., Gao R. Detection of SARS-CoV-2 in different types of clinical specimens. JAMA. 2020;323:1843–1844. doi: 10.1001/jama.2020.3786. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.World Health Organization (WHO) WHO; Geneva, Switzerland: 2020. Coronavirus disease (COVID-19) technical guidance: early investigation protocol. [Google Scholar]
- 5.Scott J., Humphreys D.R. Dissecting aortic aneurysm and disseminated intravascular coagulation. Br Med J. 1977;1:24. doi: 10.1136/bmj.1.6052.24. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Gatate Y., Masaki N., Sato A. Tranexamic acid controlled chronic disseminated intravascular coagulation associated with aortic dissection and patent false lumen for three years. Intern Med. 2017;56:925–929. doi: 10.2169/internalmedicine.56.7499. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Ng K.T., Van Paassen J., Langan C. The efficacy and safety of prophylactic corticosteroids for the prevention of adverse outcomes in patients undergoing heart surgery using cardiopulmonary bypass: a systematic review and meta-analysis of randomized controlled trials. Eur J Cardiothorac Surg. 2020;57:620–627. doi: 10.1093/ejcts/ezz325. [DOI] [PubMed] [Google Scholar]
- 8.Zhou F., Yu T., Du R. Clinical course and risk factors for mortality of adult in patients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054–1062. doi: 10.1016/S0140-6736(20)30566-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Lillicrap D. Disseminated intravascular coagulation in patients with 2019-nCoV pneumonia. J Thromb Haemost. 2020;18:786–787. doi: 10.1111/jth.14781. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Thachil J., Tang N., Gando S. ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost. 2020;18:1023–1026. doi: 10.1111/jth.14810. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Tang N., Li D., Wang X. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18:844–847. doi: 10.1111/jth.14768. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Fogarty H., Townsend L., Ni Cheallaigh C. COVID19 coagulopathy in Caucasian patients. Br J Haematol. 2020;189:1044–1049. doi: 10.1111/bjh.16749. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.McGonagle D., Sharif K., O'Regan A. The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease. Autoimmun Rev. 2020;19 doi: 10.1016/j.autrev.2020.102537. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Tang N., Bai H., Chen X. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. 2020;18:1094–1099. doi: 10.1111/jth.14817. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Fox S.E., Akmatbekov A., Harbert J.L. Pulmonary and cardiac pathology in Covid-19: the first autopsy series from New Orleans [e-pub ahead of print] Lancet Respir Med. 2020 May 27 doi: 10.1016/S2213-2600(20)30243-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Luo W., Yu H., Gou J. Clinical pathology of critical patient with novel coronavirus pneumonia (COVID-19) Preprints. 2020 [Google Scholar]
- 17.McGonagle D., O'Donnell J.S., Sharif K. Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia. Lancet Rheumatol. 2020;2:e437–e445. doi: 10.1016/S2665-9913(20)30121-1. [DOI] [PMC free article] [PubMed] [Google Scholar]

